Pulmonary inflammation and glucocorticoid sensitivity for the prediction of bronchopulmonary dysplasia (PRIDICT-BPD): a feasibility study
Recruiting
- Conditions
- Bronchopulmonary dysplasia
- Registration Number
- NL-OMON23788
- Lead Sponsor
- Stichting Steun Emma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Prematurity <30 weeks GA
Exclusion Criteria
Major congenital malformation
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To test whether the assays described above are feasible in this patient group to develop a prediction model for BPD in the future.
- Secondary Outcome Measures
Name Time Method To test whether the outcomes of the assays are associated with the development of BPD and the duration of respiratory support;<br>To test whether the outcomes of these assays are associated with pro-inflammatory markers;<br>To test the relative contribution of cortisol, 17-OH progesterone, and 11-deoxycortisol to GBA.